Hyperparathyroidism is characterized by the discharge of the parathyroid hormone (PTH). The disease can be categorized as primary, secondary, or tertiary [1,2]. Primary hyperparathyroidism (PHPT) is defined as the most frequent disease of the parathyroid glands and one of the most frequent endocrine disorders [3].

The most prevalent and recurring complication of end-stage renal disease is secondary hyperparathyroidism (sHPT). If present, it increases cardiovascular morbidity and mortality [4,5].

There is an increased incidence in Europe, with an incidence in Sweden of 3% of women and 0.7% of men over the age of 60, and an annual rate of 16 per 100,000 reported in Denmark [6,7].

The prevalence in Europe of renal sHPT is predicted at around 8.5% in the United Kingdom, 8.2% in France, and at a lower prevalence in Spain and Portugal (6.8% and 6.1%) [8].

The treatment options, depending on the type and severity of hyperparathyroidism, are as follows: follow up in cases with asymptomatic primary hyperparathyroidism; surgical treatment in symptomatic primary hyperparathyroidism; surgical treatment in upgraded asymptomatic primary hyperparathyroidism.

KDIGO guidelines recommend that, when serum PTH level is higher than 800 pg/mL and the patient presents hypercalcemia (calcium > 10.4 mg/dL) with hyperphosphatemia which is non-respondent to medical treatment, parathyroidectomy should be considered, especially in patients before renal transplantation [9,10]. Symptomatic patients are also candidates for parathyroidectomy [9].

When considering parathyroidectomy for treatment, a correct apperception of the location of the glands is compulsory.

Ultrasonography is the most sought for examination for thyroid disease because of its important role in the management and diagnosis of thyroid nodules [11].

Elastography is a somewhat novel technique that can be used to assess tissue stiffness with the potential of differentiating benign from malignant tissues [12,13].

Elastography has proved his usefulness in many areas of medicine and it has been recognized as a marker of pathological state [14]. By improving diagnostic methods and establishing its role in breast tumors characterization, thyroid nodules, testicular cancer, and liver pathology, studies can also be conducted on primary hyperparathyroidism [12,15,16,17,18,19,20,21].

This prospective study has the objective to determine, by using elastographic methods, the SWE characteristics of parathyroid adenoma and hyperplastic parathyroid glands from secondary hyperparathyroidism and to conclude if the technique adds novelties for the preoperative diagnostic.

The first group, evaluated from November 2018 to June 2019, contained 20 patients diagnosed with primary hyperparathyroidism. The diagnosis was confirmed by serum evaluation, identification with Technetium Sestamibi scintigraphy (MIBI), and confirmed by a pathology report after parathyroidectomy. All patients were adults with solitary parathyroid adenoma; ectopic adenomas were omitted.

The second group, evaluated in the B Braun Dialysis Center, included 120 patients, all adults known with stage 5 CKD, under hemodialysis; the hemodialysis regimen was 3 times a week. Out of the one hundred and twenty evaluated patients, fifty-nine patients had parathyroid disorders, confirmed secondary hyperparathyroidism by clinical, biological evaluation, and scan—scintigraphy or MRI for more than six months before the ultrasound examination.

We also considered patients with antecedents of subtotal parathyroidectomy, whom at the moment presented other parathyroid glands enlargement on ultrasound. The final analysis included all the identified glands, even if one or more parathyroid glands were visible in each patient.

Excluded from the analysis were ectopic parathyroid glands and cases with secondary adynamic bone disease, or secondary hyperparathyroidism who underwent total parathyroidectomy.

The studies were approved by the Ethics Committee and all patients signed written consent. The study followed the Ethics Code of the World Medical Association.

Twenty patients with primary hyperparathyroidism were studied (male to female ratio 1/19), mean age 57.3 ± 13.33, mostly postmenopausal women, and 59 patients (male to female ratio 27/32), mean age 56.95 ± 10.92, mostly above 65 years old, with confirmed CKD stage 5, on hemodialysis. Conventional ultrasound examination and 2D-SWE elastography were completed, as the results and baseline characteristics are described in Table 1.

A total number of 20 parathyroid adenomas (first lot) and 97 hyperplastic parathyroid glands (second lot) were studied.

For each parathyroid gland studied, 5 measurements were performed. We have also made the same measurements for normal thyroid tissue and muscle tissue, in order to compare them with the parathyroid tissue. Described in Table 2 are the SWE results, taking into consideration the following parameters: minimum SWE; maximum SWE; and the mean SWE for parathyroid, thyroid and muscle tissue.

In the first lot, for the parathyroid adenomas, a one-way ANOVA test demonstrated a statistically significant difference when measured by 2D-SWE, between parathyroid elasticity (kPa) compared with thyroid and muscle elasticity (p < 0.001) (Figure 3).

A significance level at p < 0.008, with higher parathyroid adenoma elasticity (4.74 ± 2.745 kPa) compared with normal thyroid tissue (11.718 ± 4.206 kPa), respectively, surrounding muscles (16.362 ± 3.829 kPa) was determined using post hoc analysis with the T test and a Bonferroni correction applied. The difference is important when comparing SWE mean values of parathyroid adenomatous tissue with thyroid parenchyma (mean difference = −6.978 kPa, p < 0.001), respectively, with mean SWE muscle values (mean difference = 11.622, p < 0.001) [39].

As for the quantitative measurements obtained, we have calculated using AUROC curve, sensitivity, specificity, accuracy and cut-off values for the measured parameters, as presented in Table 3. After analysis, we established that the preferred accuracy is by analyzing the mean SWE value, with a value of 92.5% for the parathyroid/thyroid couple and 97.5% for the parathyroid/muscle couple, followed by the min SWE value with an accuracy of 90.0% and 97.5%, respectively. Taking these data into account, whenever borderline values are found, Min SWE and max SWE values could be useful tools by helping to discriminate structures and positively identify parathyroid adenomas [40].

Using ANOVA test and post hoc analysis with Tukey’s test, we have found that for the secondary hyperparathyroidism lot, statistically significant difference for the mean SWE parathyroid values, compared with thyroid SWE (−5.945, p < 0.001) and with muscle (−7.953, p < 0.001) (Figure 4) [39].

The discerning power of elastography US examination was assessed using the Receiver Operating Characteristic Curve (ROC), comparing the mean SWE value of the parathyroid tissue with the mean SWE of the surrounding muscle. The Area Under Curve (AUC) was 0.949, 95% CI (0.917; 0.980). In conclusion, a value less than 9.98 kPa has a specificity of 90.7%, sensitivity of 93.8%, and accuracy of 91.75%, in identifying parathyroid adenoma using muscle as a reference (Figure 5) [38].

The ROC curve evaluated the SWE mean values for parathyroid tissue in relation to SWE mean values for thyroid tissue, with an AUC of 0.940 with 95% CI (0.903; 0.978) (Figure 6). Lastly, a value less than 9.74 kPa has a specificity of 90.7%, sensitivity of 94.8%, and accuracy of 92.26%, in differentiating parathyroid tissue, about thyroid tissue [39].

To resume, we have elaborated an algorithm for the evaluation of patients with suggestive symptoms or asymptomatic of primary or secondary hyperparathyroidism and how to use elastography to improve diagnostic accuracy (Figure 7).

The study point of this article was to evaluate and compare the determined tissue elasticity index of parathyroid adenomas from PHPT and parathyroid hyperplasia from sHPT by using shear wave elastography. The elastographic values of the parathyroid adenoma and parathyroid hyperplasia were then compared to the elastographic features of the surrounding thyroid and sternocleidomastoid muscle. For the primary hyperparathyroidism lot, we had confirmation by biological evaluation, identification by Technetium Sestamibi scintigraphy (MIBI), and certification by morphopathology report after parathyroidectomy. For the secondary hyperparathyroidism lot, we included hyperplastic parathyroid glands that were initially localized in conventional B-mode ultrasonography and confirmed using parathyroid Technetium Sestamibi scintigraphy.

Elastography is a novel ultrasound technique for the parathyroid field, as there are no international guidelines for primary or secondary hyperparathyroidism. There is no “when and why” for parathyroid ultrasound in the management of primary or secondary hyperparathyroidism.

Elastography is gaining ground in the parathyroid exploration, as there are several studies in the literature on primary hyperparathyroidism, demonstrating the usefulness of this technique [40].

By studying parathyroid elastography, we concluded that tissue stiffness of parathyroid adenoma is best assessed by using mean SWE, correctly identifying parathyroid tissue. A mean (±SD) SWE value of 4.74 ± 2.745 kPa was found for all parathyroid adenomas enrolled in the study. When we compared the mean SWE values of thyroid tissue (mean SWE value 11.718 ± 4.206 kPa) and surrounding muscle tissue (mean SWE value 16.362 ± 3.829 kPa), we found that the elasticity of parathyroid adenoma was significantly lower than them both. For this lot, we have constituted that the most reliable index is mean SWE, with a cut-off value for correctly identify parathyroid adenomas below 7 kPa.

Elastographic measurements of parathyroid hyperplasia for secondary hyperparathyroidism could be useful in diagnosing and treating parathyroid hyperplasia and preventing tertiary hyperparathyroidism. The mean SWE value found for hyperplastic parathyroid glands enrolled in the study was 7.83 ± 2.94 kPa. By comparing the mean SWE values of parathyroid tissue with the values obtained for thyroid tissue (13.780 ± 4.039 kPa) and surrounding muscle (15.788 ± 4.409 kPa), we established that parathyroid elasticity is significantly lower than both thyroid and muscle tissue. A cut-off value of below 9.74 kPa presented a sensitivity and specificity of 94% and 90%, respectively, for identifying parathyroid tissue in comparison with thyroid tissue. If compared with muscle tissue, a value of below 9.98 kPa had a specificity and sensitivity of 90% and 93%, respectively, for identifying parathyroid tissue in comparison with muscle tissue.

There are literature studies that have determined thresholds for parathyroid elastography, using different elastographic measurements: using the SWE VTIQ method, the mean SWV of parathyroid adenomas (2.16 ± 0.33 m/s) was higher than the mean SWV of parathyroid hyperplasia (1.75 ± 0.28 m/s), with a cut-off value greater than 1.92 m/s for diagnosing parathyroid adenoma [23,39].

Studies in the literature on parathyroid adenomas, conducted using SWE VTIQ, concluded that parathyroid adenomas have a lower mean value, determined at 2.01 m/s (±0.24) compared with the normal thyroid tissue—2.77 m/s [19]. By using ARFI imaging, 2D-SWE parathyroid adenomas (mean SWV value of 3.09 ± 0.75 m/s) present lower elasticity than benign thyroid nodules (2.20 ± 0.39 m/s) and a higher elasticity compared to malignant thyroid lesions (3.59 ± 0.43 m/s) [41].

Another study conducted on 2D-SWE for parathyroid adenomas found a mean SWE value of 5.2 ± 7.2 kPa, significantly lower than thyroid nodules—24.3 ± 33.8 kPa—thus, concluding that parathyroid adenomas have lower elasticity index than benign thyroid tissue [42].

We did take into account thyroid disease and the presence of thyroid nodules, but the details are present in the dedicated article [39].

There are several literature studies that have documented elastographic assessments on parathyroid hyperplasia. Nonetheless, they were not done on patients with end-stage renal disease on hemodialysis therapy.

Multiple cut-off values were given in the literature for parathyroid hyperplasia. If determined on shear wave elastography, 1.46 m/s [20]; if determined using Elastoscan Score Index, 1.35 ± 0.61 [43]. However, we have to keep in mind that they were made on parathyroid hyperplasia from chronic kidney disease and not on patients with ESRD under RRT therapy.

The biological data gathered corroborate the observation of an important interrelationship between SWE parathyroid values and PTH values. We could not determine any correlation between parathyroid volume and SWE values, but we note that tissue elasticity does not depend on size or volume.

By elastographic evaluation, we determine tissue strain, or the difference between echo time delays achieved cross-correlating echo signals before and after tissue distortion. By keeping this in mind, we have to consider that, in parathyroid hyperplasia, the presence of chief cells dominant in the cell population in early phases of the disease and oncocytes in the advanced cases may contribute to the elastography measurement, making it dependent on the cell occupancy rate and with the phases of the disease.

There were limitations on both studied lots; firstly, the small number of patients with primary hyperparathyroidism, with an upside of the histopathological exams of the parathyroid lesions.

The main limitation for the secondary hyperparathyroidism lot was the lack of morphopathological exams in all patients, as not all patients were immediately referred to surgery. Nevertheless, the presence of parathyroid gland enlargement was certified both by ultrasonography and parathyroid scintigraphy.

After comparing the two lots of patients with primary and secondary hyperparathyroidism, we can conclude that regardless of parathyroid adenoma or parathyroid hyperplasia, on elastography, it will have a lower EI than both thyroid tissue and muscle tissue.

Parathyroid adenoma apparently presents a lower elastographic elasticity index than parathyroid hyperplasia present in renal secondary hyperparathyroidism, probably due to the cell occupancy rate and alterations due to the renal disease. However, in both cases, the EI will be lower than the thyroid elasticity index and significantly lower than the muscle tissue elasticity index.

The clinical aspect of these studies is the examination of the impact of elastography in correctly identifying and influencing the treatment decisions for patients with both primary and secondary hyperparathyroidism.

Elastography adds great value to the preoperative evaluation of patients with both primary or secondary hyperparathyroidism, as it is a simple, operator-independent, repeatable, and reproducible method that can be used complementary to conventional ultrasound. It could also correctly distinguish between thyroid and muscle tissue, when in doubt. It brings important data regarding parathyroid elasticity and it is a convenient and effective tool in the localization and study of hyperparathyroidism.

The aim of this study was to establish the value of elastography in both primary and secondary hyperparathyroidism and to determine whether it can be used to correctly identify parathyroid tissue. By using either the qualitative or the quantitative data of elastography, it brings important information and can better differentiate parathyroid tissue. By using 2D-Shear Wave Elastography, we have found that a value less than 7 kPa is suggestive for parathyroid adenomas and less than 9.98 kPa is suggestive for parathyroid tissue in patients with secondary hyperparathyroidism. Further studies in the field of parathyroid elastography are required in order to establish its value in the localization and treatment of hyperparathyroidism.